Security key
83422E105
Solid Biosciences Inc. - Common Stock $0.001 par value per share (SLDB)
CUSIP: 83422E105
Q2 2023 13F Holders as of 30 Jun 2023
- Type / Class
- Equity / Common Stock $0.001 par value per share
- Shares outstanding
- 100,767,588
- Total 13F shares
- 72
- Share change
- 0
- Total reported value
- $377
- Price per share
- $5.20
- Number of holders
- 2
Report period
Q2 2023
Institutions
2
Top holders
2
SLDB full security history
Newer quarter: Q3 2023
Previous quarter: Q1 2023
Solid Biosciences Inc. SEC filings
Solid Biosciences Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 83422E105
Recent filing periods:
Top shareholders of SLDB - Solid Biosciences Inc. - Common Stock $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
3.8%
|
3,495,933
|
$16,570,722 | — | 31 Mar 2023 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
3.7%
|
3,426,286
|
$16,240,596 | — | 31 Mar 2023 | |
| Bain Capital Life Sciences Investors, LLC |
13F
|
Company |
3.4%
|
3,130,422
|
$14,838,000 | — | 31 Mar 2023 | |
| Camber Capital Management LP |
13F
|
Company |
1.5%
|
1,418,439
|
$6,723,000 | — | 31 Mar 2023 | |
| Laurion Capital Management LP |
13F
|
Company |
1%
|
928,169
|
$4,399,521 | — | 31 Mar 2023 | |
| Artal Group S.A. |
13F
|
Company |
0.98%
|
909,219
|
$4,310,000 | — | 31 Mar 2023 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.7%
|
646,604
|
$3,064,903 | — | 31 Mar 2023 | |
| Finepoint Capital LP |
13F
|
Company |
0.53%
|
488,857
|
$2,317,182 | — | 31 Mar 2023 | |
| CAAS CAPITAL MANAGEMENT LP |
13F
|
Company |
0.26%
|
244,518
|
$1,159,015 | — | 31 Mar 2023 | |
| PURA VIDA INVESTMENTS, LLC |
13F
|
Company |
0.24%
|
224,902
|
$1,066,035 | — | 31 Mar 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.24%
|
222,697
|
$1,055,583 | — | 31 Mar 2023 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
0.23%
|
210,405
|
$997,320 | — | 31 Mar 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.15%
|
138,761
|
$657,727 | — | 31 Mar 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.06%
|
56,335
|
$267,028 | — | 31 Mar 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.05%
|
41,911
|
$198,658 | — | 31 Mar 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.04%
|
38,763
|
$184,000 | — | 31 Mar 2023 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
34,686
|
$164,412 | — | 31 Mar 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.03%
|
23,950
|
$113,000 | — | 31 Mar 2023 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.02%
|
18,690
|
$88,591 | — | 31 Mar 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.01%
|
13,394
|
$63,488 | — | 31 Mar 2023 | |
| CIBC Asset Management Inc |
13F
|
Company |
0.01%
|
12,083
|
$57,273 | — | 31 Mar 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.01%
|
11,756
|
$55,724 | — | 31 Mar 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.01%
|
11,062
|
$52,433 | — | 31 Mar 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.01%
|
10,000
|
$47,400 | — | 31 Mar 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
4,618
|
$21,889 | — | 31 Mar 2023 | |
| BARCLAYS PLC |
13F
|
Company |
0%
|
4,417
|
$20,937 | — | 31 Mar 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
2,326
|
$11,025 | — | 31 Mar 2023 | |
| LAZARD ASSET MANAGEMENT LLC |
13F
|
Company |
0%
|
2,050
|
$9,000 | — | 31 Mar 2023 | |
| Manchester Capital Management LLC |
13F
|
Company |
0%
|
1,000
|
$4,740 | — | 31 Mar 2023 | |
| FMR LLC |
13F
|
Company |
0%
|
300
|
$1,422 | — | 31 Mar 2023 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
274
|
$1,299 | — | 31 Mar 2023 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
166
|
$1,000 | — | 31 Mar 2023 | |
| UBS Group AG |
13F
|
Company |
0%
|
166
|
$787 | — | 31 Mar 2023 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
158
|
$748 | — | 31 Mar 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
133
|
$1,000 | — | 31 Mar 2023 | |
| FIRST MANHATTAN CO. LLC. |
13F
|
Company |
0%
|
133
|
$630 | — | 31 Mar 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
123
|
$583 | — | 31 Mar 2023 | |
| Baker Avenue Asset Management, LP |
13F
|
Company |
0%
|
66
|
$313 | — | 31 Mar 2023 | |
| Parallel Advisors, LLC |
13F
|
Company |
0%
|
6
|
$28 | — | 31 Mar 2023 | |
| Rajeev M. Shah |
3/4/5
|
Director, 10%+ Owner |
—
class O/S missing
|
30,000
|
— | — | 16 Jun 2021 | |
| Joel Solomon Zev Schneider |
3/4/5
|
Chief Operating Officer |
—
class O/S missing
|
236,270
|
$1,306,573 | — | 14 Mar 2022 | |
| Carl Ashley Morris |
3/4/5
|
Chief Scientific Officer |
—
mixed-class rows
|
23,460
mixed-class rows
|
$128,883 | — | 27 Jan 2023 | |
| Erin P. Brennan |
3/4/5
|
Chief Legal Officer, Secretary |
—
class O/S missing
|
254,000
|
— | — | 02 May 2022 | |
| Robert Luther Huffines |
3/4/5
|
Director |
—
class O/S missing
|
9,650
|
— | — | 13 Dec 2022 |
Institutional Holders of Solid Biosciences Inc. - Common Stock $0.001 par value per share (SLDB) as of Q2 2023
As of 30 Jun 2023,
Solid Biosciences Inc. - Common Stock $0.001 par value per share (SLDB) was held by
2 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
72 shares.
The largest 2 holders included
Baker Avenue Asset Management, LP and Parallel Advisors, LLC.
This page lists
2
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
2
Q2 2023 holders
2
Holder diff
0
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.